세계의 임상시험 용품 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

The global market for Clinical Trial Supplies was estimated to be worth US$ 2364 million in 2024 and is forecast to a readjusted size of US$ 4099 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.

Clinical Trial Supplies refer to the comprehensive supply system of investigational products, comparators, reagents, medical equipment, and ancillary materials required throughout the entire lifecycle of clinical trials for pharmaceutical companies, biotechnology firms, and contract research organizations (CROs). Core services include the manufacturing, repackaging, labeling, batch tracking, and storage of investigational drugs, as well as the sourcing and delivery of clinical sample collection kits, companion diagnostics, and trial-specific devices. As the number of innovative drugs grows, multi-center international clinical trials become more complex, and personalized medicine advances, clinical trial supplies have become an indispensable component of pharmaceutical R&D. By integrating digital supply chain management, cold-chain logistics, and compliance-driven operations, the sector provides end-to-end, high-quality, traceable supply solutions that accelerate clinical validation and commercialization of drugs, reflecting both innovation capacity and global competitiveness in the life sciences industry.

The clinical trial supplies industry is driven by the rapid growth of global pipelines for innovative drugs and advanced therapies, as well as the rising complexity of multi-center international trials. The expanding adoption of cell and gene therapies, RNA-based drugs, and precision medicine has created a strong demand for highly customized, flexible, and compliance-oriented supply solutions. Pharmaceutical companies are increasingly investing in strategic partnerships and digital supply chain initiatives to enhance trial efficiency and regulatory adherence. In parallel, government support for drug innovation and evolving regulatory frameworks are fostering industry growth, positioning clinical trial supplies as a cornerstone of life sciences innovation.

The sector faces challenges stemming from complex global regulatory requirements and rising operational costs. Differences in GMP/GDP standards, drug distribution policies, and customs clearance procedures across countries complicate cross-border supply chains. The growing need for cold-chain transportation, batch traceability, and compliance audits necessitates ongoing investment in infrastructure, technology, and workforce training. Market competition, supply chain disruptions, geopolitical tensions, and public health crises further increase risks for global operations.

As clinical trials shift from centralized to decentralized, digital, and patient-centric models, demand for trial supplies is becoming more diversified and sophisticated. Pharmaceutical companies and CROs require greater supply chain visibility, risk management, and precise resource allocation. The rise of companion diagnostics, genomic testing, and rare disease research has fueled the demand for highly customized, small-batch supply solutions. Additionally, telemedicine and direct-to-patient (DTP) trial models are expanding service reach and flexibility, unlocking new opportunities for innovation in clinical trial logistics.

The upstream segment comprises investigational drug substances, comparator products, laboratory reagents, specialized packaging, and cold-chain transportation systems. Technological advancements by pharmaceutical manufacturers, raw material suppliers, and medical device firms have enhanced the overall quality of supply services. Smart packaging solutions, high-performance insulation equipment, and advanced temperature monitoring devices are increasingly standard. Furthermore, the adoption of digital supply chain platforms and automated warehousing is improving operational efficiency and standardization, strengthening global distribution capabilities for clinical trial supplies.

This report aims to provide a comprehensive presentation of the global market for Clinical Trial Supplies, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Clinical Trial Supplies by region & country, by Type, and by Application.

The Clinical Trial Supplies market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Supplies.

Market Segmentation

By Company

• Thermo Fisher Scientific
• Catalent Pharma Solutions
• Almac Group
• Parexel International
• UDG Healthcare
• PCI Services
• Marken
• Klifo A/S.
• Walden Group
• Bilcare Limited
• Biocair

Segment by Type

• Logistics & Distribution
• Manufacturing and Packaging
• Supply Chain Management
• Other

Segment by Application

• Phase I
• Phase II
• Phase III
• Other

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Clinical Trial Supplies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Clinical Trial Supplies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Clinical Trial Supplies in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Clinical Trial Supplies Product Introduction
• 1.2 Global Clinical Trial Supplies Market Size Forecast (2020-2031)
• 1.3 Clinical Trial Supplies Market Trends & Drivers
  • 1.3.1 Clinical Trial Supplies Industry Trends
  • 1.3.2 Clinical Trial Supplies Market Drivers & Opportunity
  • 1.3.3 Clinical Trial Supplies Market Challenges
  • 1.3.4 Clinical Trial Supplies Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Clinical Trial Supplies Players Revenue Ranking (2024)
• 2.2 Global Clinical Trial Supplies Revenue by Company (2020-2025)
• 2.3 Key Companies Clinical Trial Supplies Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies Clinical Trial Supplies Product Offered
• 2.5 Key Companies Time to Begin Mass Production of Clinical Trial Supplies
• 2.6 Clinical Trial Supplies Market Competitive Analysis
  • 2.6.1 Clinical Trial Supplies Market Concentration Rate (2020-2025)
  • 2.6.2 Global 5 and 10 Largest Companies by Clinical Trial Supplies Revenue in 2024
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Supplies as of 2024)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Logistics & Distribution
  • 3.1.2 Manufacturing and Packaging
  • 3.1.3 Supply Chain Management
  • 3.1.4 Other
• 3.2 Global Clinical Trial Supplies Sales Value by Type
  • 3.2.1 Global Clinical Trial Supplies Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Clinical Trial Supplies Sales Value, by Type (2020-2031)
  • 3.2.3 Global Clinical Trial Supplies Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Phase I
  • 4.1.2 Phase II
  • 4.1.3 Phase III
  • 4.1.4 Other
• 4.2 Global Clinical Trial Supplies Sales Value by Application
  • 4.2.1 Global Clinical Trial Supplies Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Clinical Trial Supplies Sales Value, by Application (2020-2031)
  • 4.2.3 Global Clinical Trial Supplies Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

• 5.1 Global Clinical Trial Supplies Sales Value by Region
  • 5.1.1 Global Clinical Trial Supplies Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Clinical Trial Supplies Sales Value by Region (2020-2025)
  • 5.1.3 Global Clinical Trial Supplies Sales Value by Region (2026-2031)
  • 5.1.4 Global Clinical Trial Supplies Sales Value by Region (%), (2020-2031)
• 5.2 North America
  • 5.2.1 North America Clinical Trial Supplies Sales Value, 2020-2031
  • 5.2.2 North America Clinical Trial Supplies Sales Value by Country (%), 2024 VS 2031
• 5.3 Europe
  • 5.3.1 Europe Clinical Trial Supplies Sales Value, 2020-2031
  • 5.3.2 Europe Clinical Trial Supplies Sales Value by Country (%), 2024 VS 2031
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Clinical Trial Supplies Sales Value, 2020-2031
  • 5.4.2 Asia Pacific Clinical Trial Supplies Sales Value by Region (%), 2024 VS 2031
• 5.5 South America
  • 5.5.1 South America Clinical Trial Supplies Sales Value, 2020-2031
  • 5.5.2 South America Clinical Trial Supplies Sales Value by Country (%), 2024 VS 2031
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Clinical Trial Supplies Sales Value, 2020-2031
  • 5.6.2 Middle East & Africa Clinical Trial Supplies Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Clinical Trial Supplies Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Clinical Trial Supplies Sales Value, 2020-2031
• 6.3 United States
  • 6.3.1 United States Clinical Trial Supplies Sales Value, 2020-2031
  • 6.3.2 United States Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Clinical Trial Supplies Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Clinical Trial Supplies Sales Value, 2020-2031
  • 6.4.2 Europe Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Clinical Trial Supplies Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Clinical Trial Supplies Sales Value, 2020-2031
  • 6.5.2 China Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Clinical Trial Supplies Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Clinical Trial Supplies Sales Value, 2020-2031
  • 6.6.2 Japan Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Clinical Trial Supplies Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Clinical Trial Supplies Sales Value, 2020-2031
  • 6.7.2 South Korea Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Clinical Trial Supplies Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Clinical Trial Supplies Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Clinical Trial Supplies Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Clinical Trial Supplies Sales Value, 2020-2031
  • 6.9.2 India Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Clinical Trial Supplies Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Thermo Fisher Scientific
  • 7.1.1 Thermo Fisher Scientific Profile
  • 7.1.2 Thermo Fisher Scientific Main Business
  • 7.1.3 Thermo Fisher Scientific Clinical Trial Supplies Products, Services and Solutions
  • 7.1.4 Thermo Fisher Scientific Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
  • 7.1.5 Thermo Fisher Scientific Recent Developments
• 7.2 Catalent Pharma Solutions
  • 7.2.1 Catalent Pharma Solutions Profile
  • 7.2.2 Catalent Pharma Solutions Main Business
  • 7.2.3 Catalent Pharma Solutions Clinical Trial Supplies Products, Services and Solutions
  • 7.2.4 Catalent Pharma Solutions Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
  • 7.2.5 Catalent Pharma Solutions Recent Developments
• 7.3 Almac Group
  • 7.3.1 Almac Group Profile
  • 7.3.2 Almac Group Main Business
  • 7.3.3 Almac Group Clinical Trial Supplies Products, Services and Solutions
  • 7.3.4 Almac Group Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
  • 7.3.5 Almac Group Recent Developments
• 7.4 Parexel International
  • 7.4.1 Parexel International Profile
  • 7.4.2 Parexel International Main Business
  • 7.4.3 Parexel International Clinical Trial Supplies Products, Services and Solutions
  • 7.4.4 Parexel International Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
  • 7.4.5 Parexel International Recent Developments
• 7.5 UDG Healthcare
  • 7.5.1 UDG Healthcare Profile
  • 7.5.2 UDG Healthcare Main Business
  • 7.5.3 UDG Healthcare Clinical Trial Supplies Products, Services and Solutions
  • 7.5.4 UDG Healthcare Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
  • 7.5.5 UDG Healthcare Recent Developments
• 7.6 PCI Services
  • 7.6.1 PCI Services Profile
  • 7.6.2 PCI Services Main Business
  • 7.6.3 PCI Services Clinical Trial Supplies Products, Services and Solutions
  • 7.6.4 PCI Services Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
  • 7.6.5 PCI Services Recent Developments
• 7.7 Marken
  • 7.7.1 Marken Profile
  • 7.7.2 Marken Main Business
  • 7.7.3 Marken Clinical Trial Supplies Products, Services and Solutions
  • 7.7.4 Marken Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
  • 7.7.5 Marken Recent Developments
• 7.8 Klifo A/S.
  • 7.8.1 Klifo A/S. Profile
  • 7.8.2 Klifo A/S. Main Business
  • 7.8.3 Klifo A/S. Clinical Trial Supplies Products, Services and Solutions
  • 7.8.4 Klifo A/S. Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
  • 7.8.5 Klifo A/S. Recent Developments
• 7.9 Walden Group
  • 7.9.1 Walden Group Profile
  • 7.9.2 Walden Group Main Business
  • 7.9.3 Walden Group Clinical Trial Supplies Products, Services and Solutions
  • 7.9.4 Walden Group Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
  • 7.9.5 Walden Group Recent Developments
• 7.10 Bilcare Limited
  • 7.10.1 Bilcare Limited Profile
  • 7.10.2 Bilcare Limited Main Business
  • 7.10.3 Bilcare Limited Clinical Trial Supplies Products, Services and Solutions
  • 7.10.4 Bilcare Limited Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
  • 7.10.5 Bilcare Limited Recent Developments
• 7.11 Biocair
  • 7.11.1 Biocair Profile
  • 7.11.2 Biocair Main Business
  • 7.11.3 Biocair Clinical Trial Supplies Products, Services and Solutions
  • 7.11.4 Biocair Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
  • 7.11.5 Biocair Recent Developments

8 Industry Chain Analysis

• 8.1 Clinical Trial Supplies Industrial Chain
• 8.2 Clinical Trial Supplies Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Clinical Trial Supplies Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Clinical Trial Supplies Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer